RecruitingNCT05054413

Formulating Expert Consensus Guidelines in Cancer Care Using the Delphi Method

Key Elements for Standardized Reporting in Prostate Cancer Management: An Expert Delphi Consensus Study

Sponsor

M.D. Anderson Cancer Center

Enrollment

10 participants

Start Date

Apr 15, 2021

Study Type

OBSERVATIONAL

Conditions

Malignant Solid Neoplasm Hematopoietic and Lymphoid Cell Neoplasm

Summary

This study formulates consensus agreement on clinical key elements related to prostate cancer care that are critical for standardization and global reported using a robust Delphi technique, completely remote and electronic. The goal of this survey study is to have a panel of specialty-specific experts create a consensus agreement on a minimum set of key data elements for use in standardized reports. These recommendations would be used to develop standardized methods to report key data in electronic health records to better manage cancer patients at time of diagnosis, treatment, follow up, and into survivorship.

Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study gathers expert opinions from cancer specialists (radiation oncologists, medical oncologists, urologists, and radiation physicists) using a structured process called the Delphi method to develop consensus guidelines for treating prostate cancer. It is a survey-based study for medical professionals, not patients. **You may be eligible if...** - You are a board-certified specialist in radiation oncology, medical oncology, urology, or radiation physics - You actively treat prostate cancer patients - You are 21 or older and English-speaking **You may NOT be eligible if...** - You are not board-certified in one of the listed specialties - You do not currently treat prostate cancer patients - You are a prisoner or otherwise unable to give consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.